March 25, 2025
TOPLINE: Drug classes such as alpha-1 blockers, atypical antipsychotics, and tricyclic antidepressants were associated with an increased incidence of intraoperative floppy iris syndrome (IFIS), with imipramine, […]
March 18, 2025
A minimally invasive surgical procedure for glaucoma designed to reduce intraocular pressure (IOP) has been found to have a high degree of success and significantly reduce […]
March 12, 2025
TOPLINE: Researchers found a strong link between increased exposure to air pollution and ocular complications, with increased exposure to nitrogen oxides (NOx) and particulate matter with […]
March 11, 2025
Continuous administration of ranibizumab with a port delivery system provides an alternative to frequent intravitreal injections for diabetic macular edema and helps delay progression of nonproliferative […]
March 10, 2025
March 7, 2025 — The FDA has approved a new gene therapy for macular telangiectasia type 2 (MacTel), a rare eye disease that causes vision loss. The […]
March 6, 2025
A gospel truth in ophthalmology has been that people of African ancestry are more likely to develop glaucoma, but a new study clouded the picture. The […]
February 28, 2025
Glaucoma is one of the three leading causes of blindness in Germany and worldwide. This neurodegenerative disease progressively damages the retinal nerve fibres, leading to irreversible […]
February 26, 2025
Community health centers are well positioned to expand vision care services such as vision testing and screening for glaucoma and retina disease to people who have […]
February 25, 2025
TOPLINE: In patients without diabetes diagnosed with overweight or obesity, the use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) led to a greater reduction in […]